Persistent Disparities in Adult Hematopoietic Cell Transplantation

David G Crockett1, Fausto R Loberiza

  • 1Section of Oncology/Hematology, Department of Internal Medicine, University of Nebraska Medical Center, 987680 Nebraska Medical Center, Omaha, NE, 68198-7680, USA, david.crockett@unmc.edu.

Insights

Large databases reveal persistent racial, ethnic, and socioeconomic disparities in hematopoietic cell transplants (HCT). Addressing these inequalities requires understanding and overcoming systemic barriers to equitable care.

Area of Science:

  • Hematology
  • Transplant Science
  • Health Disparities Research

Background:

  • Large databases have significantly advanced the understanding of disparities in adult hematopoietic cell transplants (HCT).
  • These disparities manifest across racial, ethnic, and socioeconomic lines at individual, institutional, and systemic levels.
  • Both allogeneic and autologous HCT are affected by these inequalities.

Purpose of the Study:

  • To review recent publications using large databases to identify disparities in HCT.
  • To place current findings within the historical context of HCT research.
  • To identify emerging themes related to inequalities in HCT.

Main Methods:

  • Systematic review of recent publications utilizing large databases.
  • Analysis of data pertaining to racial, ethnic, and socioeconomic factors in HCT outcomes.
  • Synthesis of findings to identify persistent themes and historical trends.

Main Results:

  • Persistent inequalities identified in both allogeneic HCT and autologous HCT for myeloma.
  • Emerging theme highlighting the critical need for improved homogeneity of care in HCT.
  • Disparities confirmed to exist across multiple levels of healthcare delivery.

Conclusions:

  • Minimizing inequalities in HCT is achievable through a comprehensive understanding of existing barriers.
  • Addressing systemic, institutional, and individual factors is crucial for equitable HCT access and outcomes.
  • Further research and targeted interventions are needed to promote health equity in HCT.

Related Concept Videos

Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
2.5K
Hematopoiesis01:21

Hematopoiesis

The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
10.1K
Multipotency of Hematopoietic Stem Cells01:19

Multipotency of Hematopoietic Stem Cells

The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
4.1K
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
4.4K
Distinctive Features of Adult Stem Cells vs Cancer Stem Cells01:18

Distinctive Features of Adult Stem Cells vs Cancer Stem Cells

A stem cell is an unspecialized cell that can divide without limit as needed and can, under specific conditions, differentiate into specialized cells.
Adult stem cells
Adult stem cells are tissue-specific; hence, they divide to develop the tissue from which they originate. One type of adult stem cell is the epithelial stem cell, which gives rise to the keratinocytes in the multiple layers of epithelial cells in the epidermis of the skin. Adult bone marrow has three distinct types of stem cells:...
4.9K
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.9K